Convertibles Calendar: Travere Therapeutics on tap

March 8

TRAVERE THERAPEUTICS INC.:

• $250 million seven-year convertible notes

• Greenshoe of $37.5 million

• Coupon of 1.75% to 2.25% and initial conversion premium of 32.5% to 37.5%

• Jefferies LLC, SVB Leerink LLC, BofA Securities Inc. and Evercore Inc.

• Non-callable until March 2, 2026 and then subject to a 130% hurdle

• SEC registered

• Repurchase for cash a portion of the outstanding 2.5% convertible notes due 2025 and for general corporate purposes

• San Diego-based biopharmaceutical company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.